premature ejaculation

Search with Google Search with Bing
Information
Disease name
premature ejaculation
Disease ID
DOID:13709
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00370981 Completed Phase 2 Exploratory Study of Pagoclone in Men With Premature Ejaculation. July 2006 October 2006
NCT00556478 Completed Phase 2/Phase 3 Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation October 2007 October 2009
NCT00664365 Completed Phase 1 FTIH Study With GSK958108 April 12, 2008 August 22, 2008
NCT00861484 Completed Phase 1 Proof of Mechanism in ELT November 26, 2008 December 11, 2009
NCT01021553 Completed Phase 2 A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation December 23, 2009 May 5, 2011
NCT01024491 Completed Phase 3 Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation August 2008 April 2009
NCT01183208 Completed Phase 1 A Safety and Tolerability Study of Administration of PSD502 December 2009 February 2010
NCT01184105 Completed Phase 1 A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation September 2010 November 2010
NCT01203202 Completed Phase 2 Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation September 2010 January 2011
NCT01419470 Completed Phase 1/Phase 2 Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 February 2011 May 2012
NCT01439984 Completed Phase 3 Trial of PED-1 in Male Patients With Premature Ejaculation September 2011 June 2012
NCT02232425 Completed Phase 2 IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) September 2014 October 2015
NCT02297152 Completed N/A A New Treatment for Premature Ejaculation? May 2014 October 2014
NCT02572037 Completed Research and Clinical Value of New Classification for Premature Ejaculation: Multi-Center Research October 2015 July 30, 2017
NCT02794454 Completed N/A A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health May 2016 January 2017
NCT02844998 Completed N/A The Impact and Benefit of Physical Activity on Premature Ejaculation January 2015 July 2016
NCT02939495 Completed Phase 4 The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy October 2016 August 2017
NCT02984592 Completed Effect of Exercise on Premature Ejaculation November 2016 January 31, 2017
NCT03055806 Completed Phase 2 IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE) February 28, 2017 December 6, 2017
NCT03174470 Completed N/A Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle November 2, 2016 June 30, 2017
NCT03204890 Completed N/A TPTNS for Treating Patients With Premature Ejaculation June 14, 2017 October 30, 2018
NCT03304808 Completed N/A Efficacy of a New Behavioral Treatment for Premature Ejaculation Using a Masturbation Aid Device: Star-Stop 3.0 October 1, 2017 December 1, 2017
NCT03459833 Completed Phase 3 Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation August 19, 2016 March 2018
NCT03578783 Completed Phase 2 PSD502 in Subjects With Premature Ejaculation December 26, 2018 December 1, 2021
NCT03942367 Completed N/A Evaluation of the Safety and Effectiveness of the vPatch Device September 10, 2019 July 16, 2020
NCT04012437 Completed N/A Efficacy of App and Electronic Device in the Treatment of Premature Ejaculation July 1, 2019 December 30, 2019
NCT04085354 Completed Phase 3 Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation February 10, 2019 August 29, 2019
NCT04841395 Completed Chronotype and Premature Ejaculation June 1, 2019 December 30, 2019
NCT04850703 Completed Phase 1/Phase 2 Brain Networks Implicated in Lifelong Premature Ejaculation Patients February 2, 2021 February 4, 2023
NCT05462171 Completed The Prevalence of Erectile Dysfunction (ED) and Premature Ejaculation (PE) in Poland July 1, 2022 December 1, 2022
NCT05517694 Completed N/A Effect of Respiratory Exercises On The Intravaginal Ejaculation Latency Time January 10, 2022 January 15, 2023
NCT05964608 Completed N/A The Effect of Behavioral Therapy Given to Men and Their Partners' June 30, 2021 March 15, 2022
NCT00537459 Completed Phase 2 A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation December 2006
NCT00549211 Completed Phase 1 A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296. October 2007
NCT05556083 Not yet recruiting Phase 2 Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE) October 1, 2022 November 1, 2023
NCT05052879 Not yet recruiting Phase 3 Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation July 2024 August 2026
NCT06425211 Recruiting N/A Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation. October 30, 2021 December 2024
NCT06425224 Recruiting Phase 3 Effectiveness and Safety of TENS Therapy for Premature Ejaculation June 15, 2022 June 2025
NCT04207723 Recruiting N/A Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation July 15, 2020 December 2024
NCT06172855 Recruiting N/A The Study on the Effectiveness and Safety of Electroacupuncture at ST36 in Treating Primary Premature Ejaculation January 1, 2024 December 30, 2025
NCT00449709 Terminated Phase 1 A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects March 2007
NCT00983151 Terminated Phase 3 Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation August 2009 September 2010
NCT02378779 Terminated N/A Consultations Reason for Genital, Urinary or Psychological Humans in General Practice April 22, 2016 April 22, 2018
NCT01917006 Terminated Phase 2 A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation August 7, 2013 August 15, 2017
NCT00983736 Terminated Phase 3 Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation October 2009 September 2010
NCT03629769 Unknown status Phase 3 Effects of Proxelan Somministration in Patients With Chronic Prostatitis February 16, 2017 September 30, 2018
NCT01798667 Unknown status Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation January 2013 September 2013
NCT01901029 Unknown status Male Reproductive Health of Floating Population: a Large-Scale Survey in Dongguan July 2013 September 2013
NCT02028013 Unknown status Management of Sexual Dysfunction With Bioresonance Technique January 2013 August 2016
NCT02109302 Unknown status N/A Primary Premature Ejaculation Genetics
NCT03879746 Unknown status Phase 3 Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride April 2019 May 2020
NCT02241460 Unknown status Phase 3 Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation March 2014 December 2015
NCT02571101 Unknown status Phase 2 A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation November 2015 June 2016
NCT02581826 Unknown status Phase 2 Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation October 2013 December 2016
NCT04235192 Unknown status A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province July 31, 2019 October 1, 2020
NCT04361305 Unknown status Phase 3 Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction June 3, 2020 April 1, 2021
NCT03018743 Unknown status Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation January 2017 January 2020
NCT04703127 Unknown status Phase 3 Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. March 30, 2020 January 30, 2021
NCT00656552 Unknown status Early Phase 1 Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation May 2008
NCT05749614 Unknown status N/A Precise Use of Lidocaine Cream to Treat Primary Premature Ejaculation March 1, 2022 April 1, 2023
NCT03177226 Unknown status N/A Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation January 2017 December 2017
NCT03177746 Unknown status Phase 4 The Safety of Dapoxetine/Tadalafil Combination Therapy December 31, 2022 October 14, 2023
NCT04941690 Unknown status Erectile Dysfunction, Psychological Disorders, and Sexual Performance Among Men Seeking Medical Help for Fertility June 26, 2021 March 2022
NCT05183334 Unknown status Phase 4 Combined On-demand Sildenafil Citrate and Tramadol Hydrochloride for Treatment of Premature Ejaculation December 30, 2021 December 25, 2022
NCT03583112 Unknown status N/A Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients July 10, 2018 December 2018
Disase is a (Disease Ontology)
DOID:10132
Cross Reference ID (Disease Ontology)
ICD10CM:F52.4
Cross Reference ID (Disease Ontology)
ICD9CM:302.75
Cross Reference ID (Disease Ontology)
MESH:D061686
Cross Reference ID (Disease Ontology)
NCI:C94349
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:123302009
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0033038
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0012876
ICD10 preferred id (Insert disease from ICD10)
D0004625
ICD10 class code (Insert disease from ICD10)
F52.4
MeSH unique ID (MeSH (Medical Subject Headings))
D061686